{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T05:01:55Z","timestamp":1749358915987,"version":"3.37.3"},"reference-count":9,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,2]]},"DOI":"10.1182\/blood-2016-12-757336","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T12:30:17Z","timestamp":1486038617000},"page":"539-540","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Fall of the mutants: T cells targeting BCR-ABL"],"prefix":"10.1182","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-2331","authenticated-orcid":false,"given":"Premal","family":"Lulla","sequence":"first","affiliation":[{"name":"BAYLOR COLLEGE OF MEDICINE;"},{"name":"TEXAS CHILDREN\u2019S HOSPITAL; AND"},{"name":"HOUSTON METHODIST HOSPITAL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-7698","authenticated-orcid":false,"given":"Helen E.","family":"Heslop","sequence":"additional","affiliation":[{"name":"BAYLOR COLLEGE OF MEDICINE;"},{"name":"TEXAS CHILDREN\u2019S HOSPITAL; AND"},{"name":"HOUSTON METHODIST HOSPITAL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"author":"Comoli","key":"2019111903201049500_B1","first-page":"582"},{"issue":"5","key":"2019111903201049500_B2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2005-11-4386","article-title":"Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"108","author":"Wassmann","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2019111903201049500_B3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/cncr.23666","article-title":"Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors","volume":"113","author":"Jones","year":"2008","journal-title":"Cancer"},{"issue":"26","key":"2019111903201049500_B4","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2019111903201049500_B5","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1172\/JCI82416","article-title":"Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes","volume":"125","author":"Cohen","year":"2015","journal-title":"J Clin Invest"},{"issue":"8","key":"2019111903201049500_B6","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2009-06-230391","article-title":"Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment","volume":"115","author":"Riva","year":"2010","journal-title":"Blood"},{"issue":"7614","key":"2019111903201049500_B7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature18945","article-title":"Neoantigen landscape dynamics during human melanoma-T cell interactions","volume":"536","author":"Verdegaal","year":"2016","journal-title":"Nature"},{"issue":"6280","key":"2019111903201049500_B8","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"issue":"23","key":"2019111903201049500_B9","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-cell transfer therapy targeting mutant KRAS in cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/5\/539\/1401247\/blood757336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/5\/539\/1401247\/blood757336.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:20:19Z","timestamp":1574133619000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/5\/539\/36146\/Fall-of-the-mutants-T-cells-targeting-BCRABL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,2,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-12-757336","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}